                         SEQUENCE LISTING

<110>  Novartis AG
       Bagdanoff, Jeffrey T
       Chen, Zhuoliang
       Dore, Michael
       Fortanet, Jorge Garcia
       Kato, Mitsunori
       LaMarche, Matthew J
       Sarver, Patrick James
       Schultz, Michael
       Smith, Troy Douglas
       Williams, Sarah
 
<120>  COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

<130>  PAT056867-WO-PCT

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  biphosphorylated peptide derived from insulin

       receptor substrate-1 (IRS-1)


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  PHOSPHORYLATED TYROSINE

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  dPEG8

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  PHOSPHORYLATED TYROSINE

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  AMIDATED LYSINE

<400>  1

Leu Asn Xaa Ile Asp Leu Asp Leu Val Xaa Leu Ser Thr Xaa Ala Ser 
1               5                   10                  15      


Ile Asn Phe Gln Xaa 
            20      


